Zdrowie i gospodarka · 03/08/2023

FDA to Host Public Meeting on Mitigating Clinical Study Disruptions During Disasters and Public Health Emergencies

The FDA is hosting a public meeting to discuss ways to minimize disruptions to clinical studies of medical products during disasters and public health emergencies, in response to the COVID-19 pandemic and mandated by the Food and Drug Omnibus Reform Act of 2022.